Old Web
English
Sign In
Acemap
>
authorDetail
>
Leda Mannent
Leda Mannent
Sanofi S.A.
Dupilumab
Medicine
Internal medicine
in patient
Inflammation
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dupilumab Improves Health-Related Quality of Life (HRQoL) and Reduces Symptom Burden in Patients with Eosinophilic Esophagitis (EoE): Results From Part A of a Randomized, Placebo-Controlled Three-Part Phase 3 Study
2021
The Journal of Allergy and Clinical Immunology
Evan S. Dellon
Marc E. Rothenberg
Ikuo Hirano
Mirna Chehade
Albert J. Bredenoord
Jonathan M. Spergel
Qiong Zhao
Bethany Beazley
Isabelle Guillemin
Leda Mannent
Elizabeth Laws
Nikhil Amin
Brad Shumel
Jennifer Maloney
Siddhesh Kamat
Show All
Source
Cite
Save
Citations (0)
Dupilumab Treatment Leads to Clinical Asthma Remission in Patients With Uncontrolled Moderate-to-Severe Asthma With Type 2 Inflammation
2021
The Journal of Allergy and Clinical Immunology
Ian D. Pavord
William W. Busse
Elliot Israel
Stanley J. Szefler
Zhen Chen
Nadia Daizadeh
David J. Lederer
Leda Mannent
Nikhil Amin
Elizabeth Laws
Marcella Ruddy
P Rowe
Yamo Deniz
Asif Khan
Yi Zhang
Show All
Source
Cite
Save
Citations (0)
Dupilumab Reduces Blood, Urine, and Nasal Biomarkers of Type 2 Inflammation in Patients With Chronic Rhinosinusitis With Nasal Polyps in the Phase 3 SINUS-52 Trial
2020
The Journal of Allergy and Clinical Immunology
Claus Bachert
Seong Ho Cho
Tanya M. Laidlaw
Brian N. Swanson
Sivan Harel
Leda Mannent
Nikhil Amin
Alexandre Jagerschmidt
Show All
Source
Cite
Save
Citations (1)
1
map